Sort   by:  
 Page size 
UnknownA review of the pharmacological properties of insulin degludec and their clinical relevance.
Not available
S-EPMC4156782 | biostudies-literature
UnknownPharmacokinetic and pharmacodynamic properties of insulin degludec in Japanese patients with type 1 diabetes mellitus reflect similarities with Caucasian patients.
Not available
S-EPMC4773674 | biostudies-literature
UnknownInsulin degludec: pharmacokinetic properties in subjects with hepatic impairment.
Not available
S-EPMC3899454 | biostudies-literature
UnknownThe Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes.
Not available
S-EPMC4516859 | biostudies-literature
UnknownInsulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose-lowering effects.
Not available
S-EPMC4931208 | biostudies-literature
UnknownPharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions.
Not available
S-EPMC5394133 | biostudies-literature
UnknownGlucose-lowering effect of insulin degludec is independent of subcutaneous injection region.
Not available
S-EPMC4143594 | biostudies-literature
UnknownA General Signal Pathway to Regulate Multiple Detoxification Genes Drives the Evolution of Helicoverpa armigera Adaptation to Xenobiotics.
Not available
S-EPMC9788003 | biostudies-literature
UnknownDistinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus.
Not available
S-EPMC4065302 | biostudies-literature
UnknownFast-acting insulin aspart in Japanese patients with type 1 diabetes: Faster onset, higher early exposure and greater early glucose-lowering effect relative to insulin aspart.
Not available
S-EPMC5835461 | biostudies-literature
Sort   by:  
 Page size